Sign in

Harnessing Pluripotency

@pluripotency.bsky.social
44 followers 28 following 14 posts

Pluripotency = the power to (re)generate any body part 🌱 Fact-based insights on pluripotent stem cells & organoids for regenerative medicine Run by a transplant nephrologist / stem-cell biologist Views my own • No medical advice

PostsRepliesMedia
Reposted by Harnessing Pluripotency
Paraish S. Misra, MD PhD @paraish.bsky.social · 20/03/2026
Excited to share our new paper in Nat Comms on how human stem cell-derived pancreatic progenitors choose between islet and enterochromaffin (EC)-like fates - and how we can steer that choice! A story in a few tweets… Full paper 👉 doi.org/10.1038/s414...
doi.org
Efficient control of enterochromaffin versus islet differentiation from human pluripotent stem cell-derived pancreatic progenitors - Nature Communications
How different islet lineages emerge within pancreatic islets remains largely unknown. Here, using hPSC and mouse models, the authors identify mechanisms that influence islet versus enterochromaffin li...
143
Reposted by Harnessing Pluripotency
Sarah Crome @sarahcrome.bsky.social · 26/05/2025
🧬 Excited to share our latest study now In Press: In this study led by rising star @sarahcolpitts.bsky.social, we show that IL-10⁺ #ILC2s prevent rejection and improve islet graft survival and function in humanized mouse models. Read more: doi.org/10.1016/j.aj... #Immunology #ImmunoSky #CellTherapy
doi.org
Redirecting
1177
Harnessing Pluripotency @pluripotency.bsky.social · 26/05/2025
PART 2 - the collecting system forms 🚰
000
Harnessing Pluripotency @pluripotency.bsky.social · 26/05/2025
PART 1 - Setting up the kidney-forming niche in vitro 🔬 Using their previous protocols, they combined hPSC-UB 🌱 (RET+) and hPSC-NPCs🫘 (SIX1/2+). A simple media with only ROCK1/2 inhibitor and BMP inhibitor for 48 h was enough to induce epithelial vesicles (JAG1+/LHX1+) and a branching UB.
Immunofluorescence images showing the changes in the combined UB and NPC culture from days 0-4. GFP and RET mark the UB and SIX1, SIX2 mark the NPCs. Nephrons induced into NPCs express JAG1 and LHX1 within 48 hours.
100
Harnessing Pluripotency @pluripotency.bsky.social · 26/05/2025
BACKGROUND 🧩 A kidney forms when two cell clusters meet: • Metanephric Mesenchyme – contains NPCs that will become the filtration units/nephrons • UB – branching duct that connects with NPCs/nephrons to drain them🚰 hPSCs can make both, but getting them fuse in vitro is what today’s paper tackles.
Schematic of how the ureteric bud and the metanephric mesenchyme combine to form the kidney and its collecting system
100
Harnessing Pluripotency @pluripotency.bsky.social · 26/05/2025
HIGHLIGHTS • Optimized UB 🌱 and NPC🫘 co-culture system • NPC and UB fusion happens in vitro🧪 and in vivo🐁 • UB fuses specifically with GATA3⁺ distal nephron segments • Notch inhibition in NPCs boosts GATA3⁺ segments • WNT+TGFβ+MAPK inhibition enhances AQP2⁺ in UB-derived collecting ducts (CD)
100
Harnessing Pluripotency @pluripotency.bsky.social · 20/05/2025
🙌 Thanks for following this kidney-organoid deep-dive! What grabbed you most, and which papers or topics should Pluripotency unpack next? Drop ideas below or DM anytime. Follow for fresh #PluripotencyPrimers 🌱
012
Harnessing Pluripotency @pluripotency.bsky.social · 20/05/2025
FINAL THOUGHTS: - Important advances on methods to generate NPCs - Could this become a new cell therapy in kidney disease?💉 - If VEGF-A is the key, do we really need kidney organoids, or can find another way to give it? - More work needed to make functional, integrating kidney tissue from hPSCs! 👩‍🔬
112
Harnessing Pluripotency @pluripotency.bsky.social · 20/05/2025
SOME LIMITATIONS: -All experiments done with a single source of hPSCs - limits generalizability -NOD-SCID mice have multiple immune deficits, would NPCs behave similarly in "regular" mice (or humans)?👥 -Less than 15% of cells in the transplant were NPC-derived kidney cells. What were the rest?🤔
111
Harnessing Pluripotency @pluripotency.bsky.social · 20/05/2025
PART 4: MECHANISM OF BENEFIT Surprisingly, the NPCs did not integrate with the host kidney. Instead, they were found to produces VEGF-A after transplantation. VEGF-A hydrogels without NPCs could protect from AKI, and genetic inactivation of VEGF-A in NPCs greatly reduced their benefits.
Top: Histology pictures showing effect of unmodified NPCs and VEGF-A deficient NPCs on kidney injury. Bottom: Bar graphs quantifying the effects of saline injection, unmodified NPCs and VEGF-A deficient NPCs on histologic features of kidney injury
111
Harnessing Pluripotency @pluripotency.bsky.social · 20/05/2025
PART 3: TREATING KIDNEY DISEASE Using a mouse🐁 model of AKI (cisplatin), they made the surprising finding that histologic tubular damage and serum creatinine can be improved by NPC injection and NOT terminal organoids. Similarly, NPCs could improve fibrosis in a model of CKD (aristocholic acid)
A) Experimental schematic; B) Demonstration that NPC transplantation protects from increases in BUN and serum creatinine after aristocholic acid injection. C-D) Histology and bar graphs showing that NPC injection also protects from histologic measures of fibrosis in this model.
111
Harnessing Pluripotency @pluripotency.bsky.social · 20/05/2025
Part 2: PURIFYING NPCs USING c-MET One problem with hPSC technology is that cells don't always behave consistently. Planning for cases where cells don't differentiate to NPCs well, they found a protein specific to NPCs, "c-MET", that could be use to purify them using a technology called FACS.
Bar plots showing enrichment of key NPC genes (SIX2, SALL1, HOXD11) in NPCs sorted using the novel marker c-MET.
111
Harnessing Pluripotency @pluripotency.bsky.social · 20/05/2025
PART 1: MAKING BETTER NPCs Aiming to treat humans with kidney disease, they realized they would need to make tons of NPCs. So they first improved the method of growing these OSR1+SIX2+ NPCs in large numbers, using "CFY" media💧 containing: C: Canonical Wnt agonist F: FGF9 Y: ROCK1/2 inhibitor
Left: Images showing the effect of each factor on SIX2 and OSR1 expression. Right: Bar plot showing the effect of each factor on cell numbers.
111
Harnessing Pluripotency @pluripotency.bsky.social · 20/05/2025
BACKGROUND: Human pluripotent stem cells (hPSCs) can generate any tissue - including the kidney🫘. To do this, they must first specialize into nephron progenitors (NPCs), which are kidney-specific stem cells (can't make other organs). The authors published on this before e.g. tinyurl.com/4ufzv9pf
Schematic showing how hPSCs differentiate into NPCs and then into kidney organoids
111
Harnessing Pluripotency @pluripotency.bsky.social · 20/05/2025
HIGHLIGHTS: • A new culture medium (food for cells) helps nephron progenitors (NPCs) to grow in vitro • An new protein ("c-MET") can be used to purify NPCs • Transplanting NPCs attenuates acute (AKI) and chronic (CKD) kidney disease in mice • VEGF-A mediates this More details below ⬇️
111
Harnessing Pluripotency @pluripotency.bsky.social · 20/05/2025
📣 NEW PAPER ALERT! 🧵 I love kidney organoids - tiny nephron clusters grown in the lab from pluripotent stem cells. But can they treat kidney disease? New data suggests they can (in mice)! Let's dive in ⬇️ tinyurl.com/mr3sd6vu #KidneyOrganoids #CellTherapy #ChronicKidneyDisease #AcuteKidneyInjury
tinyurl.com
Human iPSC–derived nephron progenitor cells treat acute kidney injury and chronic kidney disease in mouse models
Expanded human iPSC–derived nephron progenitor cells secrete renoprotective factors that have therapeutic potential for AKI and CKD.
173